The objectives of this pilot study were to evaluate the efficacy and safety of 3 doses of topical alprostadil USP (prostaglandin E1) cream in comparison with placebo in 8 female patients with sexual dysfunction.
Presented at New Perspectives in the Management of Female Sexual Dysfunction
Nancy Phillips, M.D., Charletta Ayers, M.D, Raymond Rosen, Ph.D., Anita Islam, Ph.D., Jules Mitchel, Ph.D., David Ferguson, M.D., Ph.D., and James Yeager, Ph.D.
October 22, 1999
